Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3528-3536

  Oh, Donghoon ^a   Sun, Jiadong ^a   Nasrolahi Shirazi, Amir ^a,b   Laplante, Kerry L ^a   Rowley, David C ^a   Parang, Keykavous ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b CHAPMAN UNIVERSITY   (United States)

Author keywords

antimicrobial peptide; cell penetrating peptide; combination; drug delivery; methicillin resistant Staphylococcus aureus

Indexed keywords

CELL PENETRATING PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 84907965265     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5003027     Document Type: Article

References (28)

1. Moellering, R. C. MRSA: The first half century J. Antimicrob. Chemother. 2012, 67, 4-11
2. David, M. Z.; Daum, R. S. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic Clin. Microbiol. Rev. 2010, 23, 616-687
3. Klein, E. Y.; Sun, L.; Smith, D. L.; Laxminarayan, R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: A national observational study Am. J. Epidemiol. 2013, 177, 666-674
4. Klevens, R. M.; Morrison, M. A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L. H.; Lynfield, R.; Dumyati, G.; Townes, J. M. Invasive methicillin-resistant Staphylococcus aureus infections in the United States JAMA, J. Am. Med. Assoc. 2007, 298, 1763-1771
5. Chang, S.; Sievert, D. M.; Hageman, J. C.; Boulton, M. L.; Tenover, F. C.; Downes, F. P.; Shah, S.; Rudrik, J. T.; Pupp, G. R.; Brown, W. J. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N. Engl. J. Med. 2003, 348, 1342-1347
6. Steenbergen, J. N.; Alder, J.; Thorne, G. M.; Tally, F. P. Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections J. Antimicrob. Chemother. 2005, 55, 283-288
7. Hayden, M. K.; Rezai, K.; Hayes, R. A.; Lolans, K.; Quinn, J. P.; Weinstein, R. A. Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus J. Clin. Microbiol. 2005, 43, 5285-5287
8. Lister, P. D.; Wolter, D. J.; Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms Clin. Microbiol. Rev. 2009, 22, 582-610
9. Tadesse, D. A.; Zhao, S.; Tong, E.; Ayers, S.; Singh, A.; Bartholomew, M. J.; McDermott, P. F. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002 Emerging Infect. Dis. 2012, 18, 741-749
10. Gupta, K.; Scholes, D.; Stamm, W. E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women JAMA, J. Am. Med. Assoc. 1999, 281, 736-738
11. Fjell, C. D.; Hiss, J. A.; Hancock, R. E. W.; Schneider, G. Designing antimicrobial peptides: Form follows function Nat. Rev. Drug Discovery 2012, 11, 37-51
12. Lohner, K. New strategies for novel antibiotics: Peptides targeting bacterial cell membranes Gen. Physiol. Biophys. 2009, 28, 105-116
13. Lehrer, R. I.; Ganz, T. Antimicrobial peptides in mammalian and insect host defence Curr. Opin. Immunol. 1999, 11, 23-27
14. Rinaldi, A. C. Antimicrobial peptides from amphibian skin: An expanding scenario: Commentary Curr. Opin. Chem. Biol. 2002, 6, 799-804
15. Fox, J. L. Antimicrobial peptides stage a comeback Nat. Biotechnol. 2013, 31, 379-382
16. Snyder, E. L.; Dowdy, S. F. Cell penetrating peptides in drug delivery Pharm. Res. 2004, 21, 389-393
17. Vivès, E.; Schmidt, J.; Pèlegrin, A. Cell-penetrating and cell-targeting peptides in drug delivery Biochim. Biophys. Acta 2008, 1786, 126-138
18. Mandal, D.; Nasrolahi Shirazi, A.; Parang, K. Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters Angew. Chem., Int. Ed. 2011, 50, 9633-9637
19. Nguyen, L. T.; Chau, J. K.; Perry, N. A.; de Boer, L.; Zaat, S. A. J.; Vogel, H. J. Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs PLoS One 2010, 5, e12684
20. Lättig-Tünnemann, G.; Prinz, M.; Hoffmann, D.; Behlke, J.; Palm-Apergi, C.; Morano, I.; Herce, H. D.; Cardoso, M. C. Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides Nat. Commun. 2011, 2, 453
21. Oh, D.; Nasrolahi Shirazi, A.; Northup, K.; Sullivan, B.; Tiwari, R. K.; Bisoffi, M.; Parang, K. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization Mol. Pharmaceutics 2014, 11, 2845-2854
22. Epand, R. M.; Vogel, H. J. Diversity of antimicrobial peptides and their mechanisms of action Biochim. Biophys. Acta 1999, 1462, 11-28
23. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A7; National Committee for Clinical Laboratory Standards: Wayne, PA, 1997.
24. LaPlante, K. L.; Rybak, M. J. Clinical glycopeptide-intermediate Staphylococci tested against arbekacin, daptomycin, and tigecycline Diagn. Microbiol. Infect. Dis. 2004, 50, 125-130
25. Aeschlimann, J. R. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria. Insights from the society of infectious diseases pharmacists Pharmacotherapy 2003, 23, 916-924
26. Nasrolahi Shirazi, A.; Tiwari, R. K.; Oh, D.; Sullivan, B.; McCaffrey, K.; Mandal, D.; Parang, K. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters Mol. Pharmaceutics 2013, 10, 3137-3151
27. Nasrolahi Shirazi, A.; Mandal, D.; Tiwari, R.; Guo, L.; Lu, W.; Parang, K. Cyclic peptide-capped gold nanoparticles as drug delivery systems Mol. Pharmaceutics 2012, 10, 500-510
28. Madani, F.; Lindberg, S.; Langel, U.; Futaki, S.; Gräslund, A. Mechanisms of cellular uptake of cell-penetrating peptides J. Biophys. 2011, 2011, 414729